Mechanisms Establishing TLR4-Responsive Activation States of Inflammatory Response Genes by Escoubet-Lozach, Laure et al.
Mechanisms Establishing TLR4-Responsive Activation
States of Inflammatory Response Genes
Laure Escoubet-Lozach
1., Christopher Benner
1,2., Minna U. Kaikkonen
1,3, Jean Lozach
1, Sven Heinz
1,
Nathan J. Spann
1, Andrea Crotti
1, Josh Stender
1, Serena Ghisletti
1, Donna Reichart
1, Christine S. Cheng
4,
Rosa Luna
1, Colleen Ludka
5, Roman Sasik
5,6, Ivan Garcia-Bassets
7, Alexander Hoffmann
4, Shankar
Subramaniam
2, Gary Hardiman
5,6, Michael G. Rosenfeld
6,7, Christopher K. Glass
1,6*
1Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, United States of America, 2Department of Bioengineering,
University of California San Diego, La Jolla, California, United States of America, 3A. I. Virtanen Institute, Department of Biotechnology and Molecular Medicine, University
of Eastern Finland, Kuopio, Finland, 4Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, California, United States of America,
5Biomedical Genomics Microarray Laboratory (BIOGEM), University of California San Diego, La Jolla, California, United States of America, 6Department of Medicine,
University of California San Diego, La Jolla, California, United States of America, 7Howard Hughes Medical Institute, University of California San Diego, La Jolla, California,
United States of America
Abstract
Precise control of the innate immune response is required for resistance to microbial infections and maintenance of normal
tissue homeostasis. Because this response involves coordinate regulation of hundreds of genes, it provides a powerful
biological system to elucidate the molecular strategies that underlie signal- and time-dependent transitions of gene
expression. Comprehensive genome-wide analysis of the epigenetic and transcription status of the TLR4-induced
transcriptional program in macrophages suggests that Toll-like receptor 4 (TLR4)-dependent activation of nearly all
immediate/early- (I/E) and late-response genes results from a sequential process in which signal-independent factors initially
establish basal levels of gene expression that are then amplified by signal-dependent transcription factors. Promoters of I/E
genes are distinguished from those of late genes by encoding a distinct set of signal-dependent transcription factor
elements, including TATA boxes, which lead to preferential binding of TBP and basal enrichment for RNA polymerase II
immediately downstream of transcriptional start sites. Global nuclear run-on (GRO) sequencing and total RNA sequencing
further indicates that TLR4 signaling markedly increases the overall rates of both transcriptional initiation and the efficiency
of transcriptional elongation of nearly all I/E genes, while RNA splicing is largely unaffected. Collectively, these findings
reveal broadly utilized mechanisms underlying temporally distinct patterns of TLR4-dependent gene activation required for
homeostasis and effective immune responses.
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Introduction
Precise control of gene expression in response to external cues is
essential for normal development, homeostasis and immunity. In
the case of the innate immune system, which provides initial
protection against bacterial and viral pathogens through the
utilization of germ line-encoded pattern recognition receptors [1–
3], genes encoding proteins with antimicrobial and/or pro-
inflammatory activities must be rapidly and highly induced in
the presence of an infectious challenge, but maintained in a
transcriptionally repressed state under normal conditions. Toll-like
receptor 4 (TLR4) is a pattern recognition receptor for the
lipopolysaccharide (LPS) component of gram-negative bacteria [4]
and provides a widely used model system for the study of
inflammatory gene expression. TLR4 signaling in macrophages
activates hundreds of genes that contribute to anti-microbial
activity and initiate secondary inflammatory signaling pathways
that amplify acute inflammatory responses and contribute to the
development of acquired immunity. TLR4 regulates gene
expression of numerous transcription factors that drive inflamma-
tory responses, including NF-kB, AP-1 and interferon regulatory
factors (IRFs) [2,3]. These factors function in a combinatorial
manner to activate so-called immediate-early (I/E) genes in a
protein synthesis-independent manner. In addition, feed-forward
loops are built into the TLR4 response, with important examples
being the production of TNFa and type I interferons. The
production of type I interferons leads to secondary activation of
late genes containing gamma-activated sites (GAS elements)
recognized by STAT1 homodimers and genes containing
interferon-stimulated response elements (ISREs) recognized by
PLoS Genetics | www.plosgenetics.org 1 December 2011 | Volume 7 | Issue 12 | e1002401STAT1/STAT2/IRF9 complexes [5] that play roles in antimi-
crobial responses.
In addition to sequence-specific transcription factors, several
classes of co-activator and co-repressor complexes are involved in
the regulation of transcriptional responses. These complexes
harbor several enzymatic functions, including nucleosome remod-
eling and histone modifying activities. Nucleosome remodeling
activities play essential roles in controlling the accessibility of DNA
regulatory elements to sequence-specific and general transcription
factors [6]. Recent quantitative analysis of a cohort of 55
immediate/early and 12 late TLR4-responsive genes indicated
that immediate/early and late genes lacking CpG islands were
generally dependent on the activities of SWI/SNF nucleosome
remodeling activities for effective gene activation [7]. In contrast,
immediate/early and late promoters that were enriched for CpG
islands exhibited lower levels of nucleosome occupancy and LPS-
induced activation of these genes was generally independent of
SWI/SNF remodeling activities. The relatively ‘open’ chromatin
configuration of CpG island promoters may facilitate binding of
general transcription factors required for basal expression and
immediate/early transcriptional responses.
Histone modifications that include, among others, acetylation,
methylation, phosphorylation and ubiquitinylation, have been
proposed to represent a code that is interpreted by distinct classes
of architectural and regulatory proteins that in turn determine the
ability of chromatin to function as a substrate for DNA synthesis,
repair and transcription [8–10]. Trimethylation of histone H3 on
lysine 4 (H3K4me3) by Set1 in yeast [11] and orthologous
members of the Mll family of histone methyltransferases in
mammals [12] occurs on virtually all actively transcribed genes
[13]. Genome-wide studies found that the majority of protein-
encoding genes in human embryonic stem (ES) cells, liver and B
cells are marked at their promoter regions by H3K4me3, and are
occupied by RNA polymerase II (Pol II) [14]. Only a subset of
these genes appear to generate full-length transcripts in any
particular cell type, however, suggesting that H3K4 methylation
confers a permissive state enabling a gene to be receptive to
additional signals required for effective transcriptional elongation.
Acetylation of histones H3 and H4 by histone acetyltransferases
(HATs) such as CBP, p300 and p/CAF in particular has been
linked to transcriptional activation [15–18]. Acetylation of histone
H3 at K9 and K14, for example, is required for efficient
recruitment of transcription factor (TF) IID and transcriptional
initiation [17]. Furthermore, acetylation of H3K9 and H3K14 has
been shown to potentiate the PHD-dependent, high affinity
binding of TFIID to K4-methylated H3 tails [19]. Elongation
factor P-TEFb has recently been suggested to be recruited to
immediate/early TLR4-reponsive promoters that have acquired
H4K5/8/12Ac by the induced activities of GCN5 and PCAF
[20]. Histone acetylation is antagonized by histone deacetylases
(HDACs), which are thus generally associated with transcriptional
repression. Emerging evidence suggests roles of NCoR/SMRT
and CoREST corepressor complexes containing histone deacety-
lase activities in maintaining several inflammatory response genes
in a repressed state under basal conditions [20–23].
Recent genome-wide analyses [24,25] have shown that many
genes in higher eukaryotes are subject to regulation at the point
when promoter-proximal paused Pol II enters into productive
elongation, as exemplified by heat shock-induced expression of
heat shock genes, such as hsp70 [26,27]. Before induction, Pol II
pauses at the promoter-proximal region in a poised state,
established by DSIF and NELF [27], generating only short
transcripts [28]. Immediately after heat shock, P-TEFb and other
positive elongation factors are recruited, leading to release of Pol II
from pausing and productive mRNA synthesis. Promoter-
proximal pausing may thus serve to coordinate transcriptional
elongation with pre-mRNA processing. Indeed, a recent study of a
subset of immediate/early and late TLR-responsive genes
suggested that the immediate/early genes are marked by positive
histone modifications (H3K4me3, H3K9ac), presence of Pol II
and low-level expression of full-length unspliced transcripts. Upon
LPS stimulation, signal-dependent acetylation of H4K5/8/12 was
proposed to mediate recruitment of pTEFb, which in turn enabled
Pol II elongation and mRNA processing to occur [20].
In the present studies, we use a combination of genome-wide
approaches to test several features of current models and to
identify additional determinants of immediate/early and late
transcriptional responses to TLR4 ligation. We demonstrate that
nearly all immediate/early and late TLR target genes exhibit
characteristics of active genes under basal conditions regardless of
CpG content and direct detectable levels of expression of mature
mRNAs. We provide evidence that basal expression of I/E and
late genes is initially established by signal-independent transcrip-
tion factors, exemplified by PU.1, that we suggest are involved in
the initial recruitment of histone-modifying machinery. We also
find numerous differences in enriched sequence motifs that direct
basal patterns of TBP and Pol II density, induction of H4
acetylation, and enhance transcriptional elongation that we
propose collectively contribute to the distinct temporal profiles of
immediate/early and late gene activation.
Results
TLR4-responsive genes exhibit characteristics of active
genes under basal conditions
To study global relationships between histone modifications and
TLR-dependent gene expression, we performed parallel gene
expression profiling experiments and ChIP-Sequencing (ChIP-
Seq) analysis in elicited mouse peritoneal macrophages (EPM) and
bone marrow-derived macrophages (BMDM) treated with the
highly specific TLR4 agonist, Kdo2 lipid A (KLA) [29]. ChIP-Seq
was performed 1 hour after treatment with KLA or solvent control
(DMSO). Similarly, mRNA was analyzed 1 and 12 hours after
treatment with KLA or DMSO. Initial analysis focused on
immediate early genes (I/E genes), defined as genes that were
Author Summary
The innate immune response is a complex biological
program that is configured to allow host cells to rapidly
respond to infection and tissue injury. An essential feature
of this response is the sequential activation of large
numbers of genes that play roles in amplification of the
initial inflammatory response, exert anti-microbial activi-
ties, and initiate acquired immunity. Here, we use a
combination of genome-wide approaches to characterize
the basal and activated states of promoters that drive the
expression of genes that are turned on at immediate/early
or late times in macrophages following their stimulation
with a mimetic of bacterial infection. These studies identify
genetically encoded features that establish basal levels of
expression and distinct temporal profiles of signal-depen-
dent gene activation required for effective immune
responses. The general features of immediate/early and
late genes defined by these studies are likely to be
instructive for understanding how other high-magnitude,
temporally orchestrated programs of gene expression are
established.
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(Figure 1A) and late genes, defined as genes that were induced
less than 1.2-fold at 1 hour but more than 4-fold at 12 hours
(Figure 1B). These criteria identified 130 I/E and 120 late genes
(Datasets S1 and S2), respectively. Basal levels of expression of
these genes in elicited macrophages tended to be somewhat lower
than in bone marrow derived macrophages, indicating that by the
time of study, any potential prior activation of gene expression in
peritoneal macrophages due to the elicitation procedure itself had
resolved (Figure S1A, S1B). I/E genes exhibited higher promoter
Figure 1. Immediate/early (I/E) and late genes exhibit characteristics of actively transcribed genes under basal conditions. A, B.
Classification of I/E and late genes based on gene expression profiling of elicited peritoneal macrophages treated with the TLR4-specific agonist Kdo2
lipid A (KLA) for 0, 1 or 12 h. Values represent normalized, relative expression levels. Lines color-coded blue are represent genes exhibiting promoter
GC content .63%. Lines color-coded red represent genes exhibiting promoter GC content ,63%. C., D. Genome browser images of normalized tag
densities for H3K4me3, H3K9/14ac and total Pol II at the Tnf (C) and Isg20 (D) loci. E, F. Relationship of basal H3K4me3, H3K9/14ac and total Pol II at I/E
(E) and late (F) promoters.
doi:10.1371/journal.pgen.1002401.g001
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maximal discrimination between the two classes (Figure S1C).
Using this value as a cutoff, 43% of I/E promoters and 19% of late
promoters exceeded 0.63 GC content (color coded blue in
Figure 1A, 1B).
ChIP-Seq experiments initially evaluated trimethylation of
histone H3 lysine 4 (H3K4me3), acetylation of histone H3 lysines
9 and 14 (H3K9/K14ac), and total RNA polymerase II. A total of
5–8610
6 unique, mappable sequence tags were collected for each
antibody and treatment condition. Tags were assigned to a specific
promoter if they occurred within 1 kb of the transcriptional start
site (TSS) based on the global frequency distribution of these
marks (Figure S2A, S2B). Representative genome browser images
for the I/E gene Tnf and the late gene Isg20 are illustrated in
Figure 1C, 1D. Heat maps depicting promoter-associated tag
counts for I/E and late genes in elicited macrophages are
illustrated in Figure 2A and 2B, respectively, enabling visualization
of tag densities for each mark in elicited macrophages on a gene-
by-gene basis. Normalized tag counts for all of the data collected in
this study are provided in Datasets S1 and S2.
In resting macrophages, the H3K4me3 mark was enriched over
background on 89% of I/E promoters and 78% of late promoters.
This pattern was observed in both elicited peritoneal macrophages
and bone marrow derived macrophages (Figure 2A, 2B),
indicating that the H3K4me3 mark becomes established indepen-
dently of the elicitation procedure. Global alignment of the spatial
distribution of H3K4me3 tags with respect to the TSS for the 130
I/E and 120 late genes under basal conditions demonstrates a
bimodal distribution between +/21 kb of the TSS, with a nadir at
,250 bp (Figure S2A, S2B), typical of transcriptionally active
genes [30]. Although the H3K4me3 mark extends somewhat
further downstream from the TSS in I/E promoters, as a group,
both I/E and late promoters exhibit histone marks associated with
transcriptionally active genes under basal conditions and are not
distinguished by these modifications. In response to KLA, a
substantial increase of H3K4me3 enrichment was observed on I/E
genes around and downstream of the TSS (Figure S2B).
Acetylation of H3K9/14 exhibited a very similar distribution on
both classes of promoters and was highly correlated with
H3K4me3 (Figure 1E, 1F and Figure 2A, 2B). This is in line
with a recent report suggesting the presence of p300/CBP on
TLR4-responsive I/E genes under basal conditions [20]. Consis-
tent with this, mapping public p300 ChIP-Seq data for resting and
TLR4-activated bone marrow-derived macrophages [31] indicat-
ed that p300 was present on I/E promoters under basal
conditions, with lower but detectable levels also present on late
promoters (vida infra). Upon KLA stimulation, H3K9/14ac was
largely unchanged, or trended towards a decrease (Figure 1C, 1D
and Figure 2A, 2B) even though the recruitment of p300 increased
(vida infra).
The gene expression program elicited by TLR4 agonists differs
between cell types. For example, murine embryonic fibroblasts
(MEFs) are capable of responding to TLR4 signaling [32], but
exhibit a more limited response than macrophages. In contrast,
neural progenitor cells (NPCs) and embryonic stem cells (ES)
exhibit little or no response to TLR4 agonists. To assess whether
these different TLR4 responses are reflected in the promoter
H3K4me3 status, we compared ChIP-seq data for H3K4me3 in
murine embryonic fibroblasts (MEFs), neural progenitor cells
(NPCs), and embryonic stem cells (ES) from literature sources [33]
with data from macrophages (Figure 2A, 2B). Consistent with the
different scopes of their TLR4 response programs, only a subset of
TLR4-responsive genes in macrophages are marked by H3K4me3
in MEFs, while an even smaller fractions are marked in ES cells
and NPCs. These observations suggest that H3K4me3 is deposited
on the promoters of inflammatory genes prior to activation in a
cell type-specific manner consistent with the cell’s biological
functions, and is not simply a general function of promoter DNA,
such as the GC-content in these regions.
Taken together, these data indicate that most I/E and late
inflammatory genes in macrophages are characterized by the
presence of H3K4me3 and H3K9/K14ac marks under basal
conditions, exhibiting histone modifications characteristic of
actively transcribed genes. These findings are in line with the
observation that the basal levels of mRNA transcripts for the
majority of I/E and late genes are well within the range of
detection of the microarray platform or RNA sequencing
approaches used for analysis (Figure 2C, Figure S2C). Even for
genes that were not confidently identified as present by these
methods, transcripts could be identified using optimized qPCR
assays (data not shown).
Immediate/early promoters are preferentially occupied
by RNA polymerase II and regulated at the level of
transcriptional initiation and elongation
Examination of Pol II enrichment profiles revealed that I/E
genes but not late genes exhibit a striking enrichment for promoter-
associated Pol II under basal conditions, with a peak located
immediately adjacent to the first H3K4me3-positive nucleosome
downstream of the transcriptional start site (Figure 1C, Figure 2D).
As expected, most I/E genes showed a significant increase of Pol II
after 1 hour of KLA treatment, both at the promoter region and
within the transcribed region (Figure 1C, Figure 2D). These
observations are in line with recent studies suggesting that many
immediate/early TLR-responsive genes are regulated at the level of
transcriptional elongation [20]. To further evaluate this possibility
on a genome-wide scale, we performed global nuclear run-on
sequencing (GRO-Seq), allowing quantification of nascent tran-
scripts [24]. Under basal conditions, the nascent transcript density
peaks near the TSS in both I/E and late genes (Figure 3A–3D),
suggestive of the production of short RNA species. After KLA
stimulation, the nascent transcript density near TSS was signifi-
cantly increased in most I/E genes, but not in late genes, consistent
with the substantial increase in Pol II occupancy. In addition, there
wasadisproportionatelylargerincreaseinnascenttranscriptdensity
within the gene bodies of I/E genes, correlating with the marked
increase in exonic RNA tags derived from total RNA sequencing
(Figure 3C). (Total RNA sequencing tags in untreated cells are not
visible in Figure 3A and 3B due to the use of equivalent scales for
normalized tag counts). Quantification of the elongation efficiency
(tag density in gene body divided by the tag density at the TSS) for
all I/E genes is plotted in Figure 4A, and indicates that increased
elongation efficiency is a nearly universal feature of these genes.
Interestingly, we also observed an increase in the density of sense-
reads upstream of the TSS, marking potential enhancer RNAs [34],
and antisense TSS-associated RNAs [35] after KLA stimulation
(Figure 3C).
The confirmation of a marked increase in elongation efficiency,
and prior evidence that that increased processing of unspliced
transcripts contributes to I/E gene expression [20,36], prompted
us to quantify the splicing of primary transcripts by sequencing
total RNA. Analysis of strand specific RNA-Seq datasets of
,6.3610
6 uniquely mapped reads for both untreated and KLA-
treated EPMs indicated that while there were a small number of
transcripts that exhibited low splicing efficiencies under basal
conditions, the great majority of I/E transcripts were effectively
spliced under both basal and KLA-stimulated conditions
(Figure 4B, 4C).
Mechanisms Establishing TLR4-Responsive Promoters
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acetylation, coupled with the recent suggestion that H4K5/8/12ac
provides a mark for the recruitment of P-TEFb and subequent
transcriptional elongation [20], led us to evaluate the genome-wide
distribution of histone H4 acetylation. Analysis of approximately
10 million unique mappable tags for each of H4K5ac, H4K8ac
and H4K12ac under basal and KLA treatment conditions indicated
that their overall genomic distributions were very similar (Figure
Figure 2. Relationships of histone modifications and RNA polymerase II at I/E and late TLR4-responsive promoters. A, B. Heat maps of
normalized tag densities for the indicated histone marks, total RNA polymerase II (Pol II), or GRO-Seq. Values for murine embryonic fibroblasts (MEFs),
murine embryonic fibroblasts (ES), and neuronal progenitor cells (NPCs) are based on data reported in [33]. All other lanes represent values from
elicited peritoneal macrophages treated with KLA or control solvent for 1 h. C. Distribution of gene expression values as measured by DNA microarray
for I/E and late TLR-responsive genes under basal conditions. Values to the right of the gray box are considered to be confidently above signal
background. Similar results are found when using RNA-Seq to quantify expression levels (Figure S2C). D. Distribution of RNA polymerase II at I/E and
late genes.
doi:10.1371/journal.pgen.1002401.g002
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Figure2Aand 2Bandtheaggregatetagdensititesforallthreemarks
are are illustrated in Figure 4D and 4E, indicating the presence of
H4K5/8/12ac centered over both I/E and late gene promoters
under basal conditions. KLA treatment for 1 h resulted in a marked
increase in H4K5/8/12ac at I/E promoters, and a smaller but still
significant increase at late gene promoters, concomitant with an
increase of p300 occupancy. These findings corroborate on a
genome-wide scale the previous findings of both basal levels of I/E
and late gene expression and a KLA-dependent increase in H4K5/
8/12ac that could promote transition of promoter-proximal Pol II
to an elongating form at I/E promoters [20].
Sequence characteristics of I/E and late gene promoters
The finding that I/E and late genes were both marked by
H3K4me3, but that I/E genes were preferentially occupied by Pol
II under basal conditions, implied the existence of sequence
differences in their corresponding promoters that would determine
both the kinetics of gene activation and basal levels of Pol II
binding. To explore this possibility, we utilized de novo motif
discovery methods to search for enriched sequence motifs in the
proximal promoters of I/E and late genes. Motifs matching
consensus binding sites for NF-kB, AP-1/CREB and SRF
transcription factors were highly enriched among the promoters
of I/E genes, while an interferon-stimulated response element
(ISRE) and an unknown motif were the most highly enriched
sequences in the late promoters (Figure 5A), consistent with prior
studies [37]. In the case of I/E genes, these results are consistent
with the activities of NF-kB, AP-1 and SRF factors being directly
regulated by TLR4 signaling in a protein synthesis-independent
manner [3]. In the case of the late genes, the enrichment for an
ISRE sequence is consistent with induction of these genes being
dependent on a feed-forward loop involving synthesis of type I
interferons and autocrine induction IRFs.
Figure 3. Analysis of nascent RNA transcripts (GRO-Seq), total RNA, and H4 acetylation. A., B. Genome browser images of normalized tag
densities for H4K8ac and strand specific GRO-Seq, and total RNA-Seq at the Tnf (A) and Isg20 (B) loci. C, D. Strand-specific distribution of GRO-Seq tag
densities at I/E and late genes with KLA or control solvent for 1 h.
doi:10.1371/journal.pgen.1002401.g003
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of I/E and late gene activation, they do not account for the
preferential enrichment of Pol II at I/E genes. It was therefore of
interest that a TATA motif was highly enriched in I/E promoters,
but not in late promoters. Further position-specific motif analysis
directed at the region from 235 to 220 bp from the TSS
conservatively identified TATA motifs in 38% of I/E promoters,
but in only 11% of late promoters. As the TATA box is recognized
by TBP, which is a component of TFIID, we performed ChIP-Seq
analysis of TBP under basal conditions to investigate the possibility
that preferential occupancy of I/E promoters by Pol II under basal
conditions was due to preferential binding by TBP. This analysis
revealed a striking correlation of basal TBP occupancy with basal
Pol II occupancy (Figure 5B–5D), with precise spatial relationships
between TBP binding centered at 230 bp from the TSS and Pol
II binding just proximal to the first downstream nucleosome
marked by H3K4me3 and H3K9/14ac at +40 bp. In concert,
these results suggest that the preferential recruitment of Pol II to I/
E promoters under basal conditions is due to the higher frequency
of TATA box-like elements in these promoters that serve to recruit
and precisely position TBP.
H3K4me3 can be established independently of
signal-dependent transcription factors
As several different cell types are able to respond to TLR4
activation, but do so in a cell-specific manner, we considered the
possibility that H3K4me3 is a cell-restrictive signature that marks
potentially responsive target genes in a given cell type. As indicated
in Figure 2A and 2B, many of the I/E and late genes that are
enriched for H3K4me3 mark in basal conditions in macrophages
were indeed also enriched for this mark in MEFs but more rarely
in NPCs, particularly for late genes (Figure 2A, 2B). To determine
Figure 4. Quantification of elongation, splicing, and H4 actylation at I/E and late TLR4-responsive promoters. A. Gene-specific
comparison of the elongation efficiency between control and KLA at 1 h treated samples for I/E genes. Elongation efficiency was defined as the ratio
of strand-specific GRO-Seq tag density found within the gene body (+500 to +2500 bp downstream of the TSS) to the GRO-Seq tag density found at
the proximal promoter (225 bp to +175 bp). B. Gene-specific comparison of splicing efficiency between control and KLA treated total RNA-Seq
samples at 1 h for I/E genes. Splicing efficiency was defined as one minus the ratio of intron RNA-Seq tag density divided by the exon RNA-Seq tag
density for each gene. Only genes with intron and exon tag densities exceeding 1 read per kb were used included in this analysis. C. Visualization of
tag-densities mapping across 59 splice junctions in I/E genes. The density of the 39 ends of total RNA-Seq tags (32 bp in length) are plotted relative to
all RefSeq defined 59 splice junctions in I/E genes. Splicing efficiency was estimated as one minus the ratio of the density of tags confidently mapping
across the splice junction (39 end from from +7b pt o+25 bp) by the density found in the exons (39 end from 225 bp to 27 bp). D, E. Distribution of
H4ac (composed of H4K5ac/H4K8ac/H4K12ac) and p300 at I/E and late genes.
doi:10.1371/journal.pgen.1002401.g004
Mechanisms Establishing TLR4-Responsive Promoters
PLoS Genetics | www.plosgenetics.org 7 December 2011 | Volume 7 | Issue 12 | e1002401whether the H3K4me3 mark becomes established in the
macrophage lineage prior to hematopoietic differentiation, we
used ChIP to evaluate H3K4me3 status of representative
promoters in CD34
+ lin
2 hematopoietic stem cells. H3K4me3
was not detected on the Ptgs2, Cxcl10, Il1b, Nos2 or Pitx1 promoters
in these cells, but was detected on the constitutively expressed
Hdac3 promoter (Figure 6A), indicating that H3K4 trimethylation
of the TLR4-responsive promoters examined in these experiments
is established during the program of macrophage differentiation.
We next performed ChIP experiments to ascertain the presence of
H3K4me3-positive promoters in a cell line derived from PU.1-null
hematopoietic progenitor cells by transduction with a tamoxifen-
inducible form of PU.1 (PUER) [38]. Analysis of the PUER cell
line was performed in the absence of tamoxifen, in which the
functional PU.1-estrogen receptor fusion protein is present at low
levels, providing a model of an early phase of macrophage
differentiation. ChIP experiments demonstrated that the Cxcl10,
Nos2 and Ptgs2 promoters were marked by H3K4me3 in these cells
(Figure 6B).
Given that H3K4me3 is deposited during differentiation, we
sought to characterize the determinants of H3K4me3 deposition.
We considered two alternative mechanisms by which TLR4-
responsive genes might become marked by H3K4me3 in the
absence of an activating signal. One possibility is that signal-
dependent activators, such as NF-kB and IRFs, might exhibit low
levels of constitutive activity under basal conditions, sufficient to
establish H3K4 trimethylation and low levels of gene expression.
Alternatively, the H3K4me3 mark might be established by a
distinct set of sequence-specific transcription factors that are alone
not sufficient to confer high levels of transcriptional activity, but
confer responsiveness to signal-dependent activators. To investi-
gate the potential roles of NF-kB and IRF proteins in establishing
the H3K4me3 mark, we exploited MEFs derived from wild-type
embryos or embryos deficient in both p65 and IRF3. The
inflammatory response of these cells is characterized by NF-kB
and IRF-dependent activation of numerous chemokine-and
defense response-encoding genes [32]. Consistent with this, the
Cxcl10 and Nos2 genes exhibited a low level of expression in MEFs
under basal conditions and strong induction in response to KLA,
similar to results obtained in primary macrophages (Figure 6C,
6D). Furthermore, each of these genes exhibited the H3K4me3
mark under basal conditions in wild-type MEFs (Figure 6E, 66F).
Figure 5. Differential use of signal-dependent transcription factors and TBP in I/E and late promoters. A. Sequence motifs identified by
de novo motif analysis of the promoters of I/E and late genes. B. Scatter plots of normalized ChIP-Seq tag densities for Pol II and TBP in the interval
from 2100 to +250 bp from the TSS. C, D. Cumulative position-specific ChIP-Seq tag densities for H3K4me3, H3K9/14ac, Pol II and TBP determined
under basal conditions for I/E (C) and late (D) genes.
doi:10.1371/journal.pgen.1002401.g005
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responsiveness (Figure 6C, 6D), but had no measurable impact
on the presence of the H3K4me3 mark under basal conditions
(Figure 6E, 6F), strongly suggesting that the poised states of these
genes did not result from low levels of constitutive activity of the
factors responsible for TLR4-dependent gene activation.
Role of PU.1 in establishing TLR4 responses
Based on these results, we reasoned that signal-independent
factors may be involved in establishing the poised state and thus
not be enriched in promoters of TLR4-responsive genes when
compared to unresponsive genes from the same cell type. To
investigate this possibility, we took advantage of PU.1-null and
PUER cells to evaluate potential roles of the Ets factor, PU.1, in
initially establishing the H3K4me3 mark and in directing basal
expression of TLR4-responsive genes. PU.1 is required for
development of macrophages, neutrophils and B cells and
functions as a signal-independent transcriptional activator at both
promoters and enhancers [39–45]. Recent genome-wide location
studies have demonstrated that PU.1 plays an essential role in
establishing a large fraction of macrophage-specific enhancers as a
consequence of collaborative binding interactions with other
lineage-determining factors that include C/EBPs. These interac-
tions enable access and function of signal dependent factors, such
as nuclear receptors and NFkB. Although PU.1 primarily binds at
distal genomic regions, approximately 7000 of the 60,000+ PU.1
binding sites in primary macrophages reside within 500 bp of
transcriptional start sites [31,46].
To establish the relationship between PU.1 binding, deposition
of H3K4me3 and TLR4-dependent gene expression, we per-
formed ChIP-Seq analysis for H3K4me3, PUER and C/EBPb in
PU.1-null cells and in tamoxifen-treated PUER cells. In addition,
we performed GRO-Seq analysis in PU.1-null cells and tamoxifen-
induced PUER cells under control conditions and following 1 h
Figure 6. The H3K4me3 mark can be established independently of signal-dependent activators. A. The H3K4me3 mark is absent from
the Ptgs2, Cxcl10, IL1b and Nos2 promoters in Lin- hematopoietic progenitor cells. B. The H3K4me3 mark is present on the Ptgs2, Cxcl10, IL1b and Nos2
promoters in PUER myeloid progenitor cells. C, D., KLA induction of Nos2 and Cxcl10 in MEFs requires p65 and IRF3. WT or p65/IRF3 DKO MEFs were
treated for the indicated times with KLA and Nos2 (C) and Cxcl10 (F) mRNA levels were determined by Q-PCR. E, F., Q-PCR analysis of H3K4me3 at the
Nos2 and Cxcl10 promoters under basal and KLA-treated conditions in WT and p65/IRF3 DKO MEFS.
doi:10.1371/journal.pgen.1002401.g006
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within gene bodies as a measure of gene transcription, 170 genes
were induced .3-fold after 1 h KLA treatment in tamoxifen-
induced PUER cells (RPKM.0.25, FDR,10%). In the PU.1-null
cells, 48 of these 170 genes were also induced .3-fold after 1 h
KLA treatment, while 105 were unresponsive or induced less than
2-fold. These results indicate that the TLR4 signaling pathway is
intact in PU.1-null cells, and that a substantial fraction of the
TLR4-responsive genes are PU.1- dependent. Promoters that were
activated by KLA in PU.1-null and PUER cells exhibited
promoter H3K4me3 and measureable mRNA transcripts under
basal conditions in both cell types, exemplified by Slc7a11 and Relb
(Figure 7B and Figure S4C).
The majority of TLR4-responsive genes that were selectively
activated in PUER cells exhibited basal H3K4me3 in PU.1-null
cells, but were associated with distal PU.1 binding sites (.500 bp
from the TSS), consistent with roles of PU.1 in establishing signal-
dependent enhancers required for gene activation by TLR4
agonists [46]. However, reconstitution of PU.1 binding also
resulted in the ‘building’ of 212 new promoters as defined by
induction of H3K4me3 and basal mRNA expression, 18 of which
were among the set of 122 PU.1-dependent TLR4-responsive
promoters. Eight of these 18 promoters were occupied by PU.1
within 500 bp of the TSS, exemplified by the Slc15a3 (Figure 7A),
Cxcl2 and Il1rn promoters (Figure S4A, S4B), and the Emr1, Emr4,
SykB, F10 and Ccdc88b promoters (not shown), suggesting direct
roles of PU.1 in establishing H3K4me3 and basal expression. The
fraction of PU.1 promoter occupancy observed at new TLR4-
responsive promoters was similar to that of the new promoters
overall (82/212 new promoters exhibited PU.1 binding within
500 bp of the TSS). While the specific factors that build new
TLR4-responsive promoters that do not have promoter bound
PU.1 remain to be identified, these promoters are nevertheless
established during macrophage differentiation by mechanisms that
are independent of TLR4 signaling.
Discussion
The present studies indicate that nearly all immediate/early and
late TLR4-responsive promoters direct expression of measurable
levels of mature mRNA transcripts under basal conditions and
exhibit basal patterns of histone modifications (H3K4me3, H3K9/
14ac and H4K5/8/12ac) that are associated with actively
transcribed genes. Previous studies suggested that late genes might
not exhibit these features [20], but these studies examined a
relatively small set of genes at very specific genomic locations that
in retrospect appear to not be fully representative of the features of
late genes as a whole. In addition to directing detectable levels of
basal gene expression, I/E and late gene promoters exhibited
enrichment for recognition motifs for ETS, SP1 and NRF
transcription factors that are typically associated with expression
of housekeeping genes. By taking advantage of genetic and
inducible systems, we provide evidence that signal dependent
transcription factors (p65 and Irf3) are not required to establish
histone marks and basal expression of TLR4-responsive promot-
ers. In contrast, the signal-independent Ets factor PU.1 was found
Figure 7. PU.1 establishes promoter H3K4me3 and basal expression required for KLA activation of a subset of TLR4-responsive
genes. ChIP-Seq and GRO-Seq experiments were performed in PU.1-null hematopoietic progenitor cells (PU.1 KO) and in PUER cells treated with
tamoxifen for the indicated times. Genome browser images are shown for Slc5a3 (A) and Slc7a11 (B). Tracks from top to bottom are H3K4me3 tags in
PU.1 KO cells, H3K4me3 tags in PUER cells cultured for 24 h with tamoxifen, H3K4me3 tags in PUER cells cultured for 48 h with tamoxifen, PUER (PU.1
binding activity) tags in PUER cells cultured for 24 h with tamoxifen, C/EBPb tags in PU.1 KO cells, C/EBPb tags in PUER cells cultured for 24 h with
tamoxifen, mRNA-strand specific GRO-Seq tags in untreated PU.1 KO cells, mRNA-strand specific GRO-Seq tags in PU.1 KO cells treated with KLA for
1 h, mRNA-strand specific GRO-Seq tags in PUER cells cultured in tamoxifen for 24 h, and mRNA-strand specific GRO-Seq tags in PUER cells cultured in
tamoxifen for 24 h and treated with KLA for 1 h. ChIP-Seq data for PU.1 and C/EBPb is from [37].
doi:10.1371/journal.pgen.1002401.g007
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tion of a subset of these promoters. SP1 and other members of the
Ets family, particularly Ets2, have been suggested to play
analogous roles in enabling TLR4-responsiveness in macrophages
[20,47]. Notably, the use of lineage-determining factors, such as
PU.1, is likely to contribute to cell-specific responses to a variety of
different signaling pathways.
These findings suggest that rather than representing off/on
transitions, regulation of most TLR4-reponsive genes results from
a two-step process in which signal-independent factors establish
basal levels of gene expression that can then be amplified by
signal-dependent transcription factors, such as NF-kB, AP-1 and
SRF. These signal-dependent factors can act at the promoter itself,
consistent with the enrichment of their motifs within promoters, as
well as at distal enhancers that may be established in a cell-specific
manner [31,46]. This general mechanism of regulation supports
both the rapidly inducible, high dynamic range of gene expression
necessary for the synthesis of factors that are required to amplify
inflammatory responses (e.g., Tnf) and exert anti-microbial
activities (e.g., Nos2), as well as the broad range of basal expression
of genes that contribute to general cellular functions (e.g., Pol II
elongation factors such as Ell2). Although it is generally considered
that genes directing the expression of factors that amplify
inflammatory responses must be kept in a tightly repressed state
under basal conditions to prevent deleterious chronic inflamma-
tion, it is also possible that the low but detectable levels of
expression of at least some of these factors serve biological
functions, such as maintenance of the immune system in a state of
readiness. In addition, the present studies examine populations of
cells, which average out the established heterogeneity in gene
expression observed at the single cell level [48].
Using a combination of genome-wide approaches, we confirm
and extend the recent observation that I/E genes are enriched for
a ‘paused’ form of Pol II immediately downstream of the TSS that
rapidly transitions to an elongating form upon TLR4 ligation.
Indeed, increased elongation efficiency in response to TLR4
ligation is observed for nearly all I/E genes. As expected, the
distinct temporal responses of I/E and late genes are highly
correlated with response elements for distinct sets of signal-
dependent transcription factors, with I/E genes exhibiting a high
degree of enrichment for NF-kB, AP-1 and SRF binding elements,
and late genes exhibiting enrichment for ISRE elements. The
finding that TATA boxes are preferentially enriched in I/E genes,
where they are associated with highest levels of TBP and paused
Pol II, provides genetic and experimental evidence for a signal-
independent mechanism that enables specific promoters to
become poised for rapid activation. While the TATA box can
efficiently recruit the machinery for transcriptional initiation,
signal-dependent elements appear necessary to recruit factors
necessary for productive transcriptional elongation. As 62% of the
I/E and 89% of the late promoters analyzed in these studies do
not contain obvious consensus TATA motifs, other factors must
also play roles in recruitment of TFIID, including signal-
independent factors such as ETS proteins and SP1.
ChIP-Seq experiments also confirmed the recent observation of
TLR4-induced increases in promoter-associated H4K5/8/12ac at
I/E genes [20], consistent with the possibility that this modifica-
tion mediates recruitment of pTEFb through Brd4. Although less
pronounced, significant increases in H4K5/8/12ac were also
observed at late gene promoters following 1 h of KLA treatment.
Importantly, these histone modifications are present at detectable
levels at nearly all I/E and late genes prior to activation, consistent
with our ability to detect mature transcripts from these genes. It is
notable that these marks are symmetrically distributed over the
TSS and extend over relatively long distances (.3 kb). Our
findings are consistent with potential roles of p300, PCAF and
GCN5 HATs in establishing these marks [20], but how these
HATs are recruited and the mechanisms for propagation of
H4K5/8/12ac over kilobases of DNA remain to be determined.
TLR4-dependent gene promoters are held in an inactive state by
histone deacetylase (HDAC)-containing co-repressor complexes,
which are dismissed from these promoters upon TLR4 activation
[22,49]. The rapid gains of H4K5/8/12ac on both I/E and late
genes following KLA stimulation are temporally correlated with
rapid, signal-dependent turnover of NCoR and SMRT complexes
from both classes of promoters [22,49,50]. This correlation raises
the possibility that H4K5/8/12 acetylation marks are substrates
for NCoR/SMRT-associated HDAC3 activity, which could
thereby contribute to the Pol II pausing observed under basal
conditions.
The observation that the fully activated expression levels of
some TLR4-responsive genes do not reach even the basal levels of
expression of other TLR4-responsive genes (Figure 1A, 1B) further
emphasizes the point that most TLR4-dependent gene expression
represents quantitative modulation of basal levels of gene
expression, rather than a qualitative transition from ‘off’ to ‘on’
at the levels of transcriptional initiation, transcriptional elongation,
or post-transcriptional processing of RNA. The evolution of a
hierarchy of genetic elements required for TLR4-responsiveness
that are responsible for establishing active promoters (i.e. Ets, Sp1),
poised transcriptional states (TATA), and signal dependent
activation (i.e. kB, ISRE) provides multiple levels for gene-specific
regulation. Although the present findings have focused on TLR4-
dependent gene regulation, it is likely the general features of I/E
and late gene promoters defined by genome-wide and gene-
specific approaches will prove to be informative for understanding
other complex signal-dependent programs of gene expression.
Materials and Methods
Accession numbers
All ChIP-Seq, RNA-Seq, GRO-Seq and Microarray data sets
have been deposited in the NCBI GEO database (http://www.
ncbi.nlm.nih.gov/geo/) under accession number GSE23622.
Ethics statement
This study was performed in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee (IACUC) of UC San Diego (Protocol Number:
S01015), and every effort was made to minimize suffering.
Cell culture
All animal work has been conducted according to relevant
institutional, national and international guidelines. Peritoneal
macrophages were harvested by peritoneal lavage with 10 ml
ice-cold PBS 3 days after peritoneal injection of 3 ml thioglycolate.
Peritoneal cells were washed once with PBS, and seeded in 10%
fetal calf serum (FCS)/DMEM containing 100 U penicillin/
streptomycin in tissue culture-treated petri dishes overnight. Non-
adherent cells were washed off with room temperature PBS. Fresh
media was applied and cells were subjected to KLA treatment or
solvent control 24 h later. RAW264.7 cells were cultured in 10%
FCS DMEM. Thioglycollate-elicited macrophages were isolated
as previously described [51]. PU.1
2/2 and PUER cells were
propagated and the PU.1-ER fusion protein was activated with
100 nM 4-hydroxy-tamoxifen as described [46].
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enrichment of bone marrow cells for lineage-depleted cells using
the StemSep murine progenitor enrichment cocktail and StemS
device (Stem Cell Technologies, Vancouver, BC, Canada) as
previously described [52]. Murine embryo fibroblasts were
generated from E13.5 embryos and used for gene expression
and ChIP studies at passage 4–6. Rela2/2Irf32/2 MEFs were
generated by interbreeding single knockout strains [53,54].
Gene expression profiling
RNA was extracted using RNeasy kit (Qiagen, and reverse
transcribed for cDNA quantification by sybergreen Q-PCR or
hybridized to Agilent or Illumina mouse whole genome expression
arrays. Biological triplicates were evaluated for each time point,
with untreated samples serving as controls. RNA expression
profiles of several genes were confirmed after reverse transcription
by quantitative PCR. A combination of statistical approaches was
used to define significant changes in gene expression [55,56].
Chromatin immunoprecipitation (ChIP)
ChIP was performed as described previously [57], with
modifications. Briefly, 10–20610
6 cells were crosslinked in 1%
Formaldehyde/PBS for 10 minutes at room temperature. The
reaction was quenched by adding glycine to a final concentration
of 125 mM, and the cells were centrifuged immediately (5 min,
7006 g, 4uC) and washed twice with ice-cold PBS. Cells were
resuspended in swelling buffer (10 mM HEPES/KOH pH 7.9,
85 mM KCl, 1 mM EDTA, 0.5% IGEPAL CA-630, 16protease
inhibitor cocktail (Roche), 1 mM PMSF) for 5 minutes. Cells were
spun down and resuspended in 500 ml lysis buffer (50 mM Tris/
HCl pH 7.4@20uC, 1% SDS, 0.5% Empigen BB, 10 mM EDTA,
16 protease inhibitor cocktail (Roche), 1 mM PMSF)) and
chromatin was sheared to an average DNA size of 300–400 bp
by administering 6 pulses of 10 seconds duration at 12 W power
output with 30 seconds pause on wet ice using a Misonix 3000
sonicator. The lysate was cleared by centrifugation (5 min,
160006g, 4uC), and 500 ml supernatant was diluted 2.5-fold with
750 ml dilution buffer (20 mM Tris/HCl pH 7.4@20uC, 100 mM
NaCl, 0.5% Triton X-100, 2 mM EDTA, 16 protease inhibitor
cocktail (Roche)). The diluted lysate was pre-cleared by rotating
for 2 h at 4uC with 120 ml 50% CL-4B sepharose slurry
(Pharmacia, Uppsala, Sweden; Before use, up to 250 ml CL-4B
sepharose were washed twice with TE buffer, blocked for
.30 min at room temperature with 0.5% BSA and 20 mg/ml
glycogen in 1 ml TE buffer, washed twice with TE and brought up
to the original volume with TE). The beads were discarded, and
1% of the supernatant were kept as ChIP input. The protein of
interest was immunoprecipitated by rotating the supernatant with
2.5 mg antibody overnight at 4uC, then adding 50 ml blocked
protein A-sepharose CL-4B (GE Healthcare, Piscataway, NJ,
USA; protein A-sepharose CL-4B was blocked as CL-4B above,
except that it was rotated overnight at 4uC) and rotating the
sample for an additional 1 K to 2 h at 4uC. The beads were
pelleted (2 min, 10006g, 4uC), the supernatant discarded, and the
beads were transferred in 400 ml wash buffer I (WB I) (20 mM
Tris/HCl pH 7.4@20uC, 150 mM NaCl, 0.1% SDS, 1% Triton
X-100, 2 mM EDTA) into 0.45 mm filter cartridges (Ultrafree
MC, Millipore, Billerica, MA, USA), spun dry (1 min, 22006 g,
4uC), washed one more time with WB I (20 mM Tris/HCl
pH 7.4@20uC, 150 mM NaCl, 0.1% SDS, 1% Triton X-100,
2 mM EDTA), and twice each with WB II (20 mM Tris/HCl
pH 7.4@20uC, 500 mM NaCl, 1% Triton X-100, 2 mM EDTA),
WB III (10 mM Tris/HCl pH 7.4@20uC, 250 mM LiCl, 1%
IGEPAL CA-630, 1% Na-deoxycholate, 1 mM EDTA), and TE.
Immunoprecipitated chromatin was eluted twice with 100 ml
elution buffer each (100 mM NaHCO3, 1% SDS) into fresh tubes
for 20 min and 10 min, respectively, eluates were pooled, the Na
+
concentration was adjusted to 300 mM with 5 M NaCl and
crosslinks were reversed overnight at 65uC in a hybridization oven.
The samples were sequentially incubated at 37uC for 2 h each
with 0.33 mg/ml RNase A and 0.5 mg/ml proteinase K. The
DNA was isolated using the QiaQuick PCR purification kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. Antibodies against PU.1 (sc-352) and Pol II (sc-899
X) were purchased from Santa Cruz Biotech (Santa Cruz, CA,
USA). Antibodies against H3K4me3 (ab8580) were from Abcam
(Cambridge, MA, USA), and antibodies recognizing H4K5/6/
12ac (07-327, 07-328, 07-595) and H3K9/14ac (06-599) were
from Millipore (Billerica, MA, USA). Information on antibody,
cell type, treatment and mapped reads is provided in Table S1.
RNA– and GRO–Seq
Peritoneal macrophages were plated onto 15 cm plates (2610
7),
serum starved and treated with KLA/DMSO. For RNA-Seq cells
were scraped and RNA purified using TRIZOL reagent
(Invitrogen, Carlsbad, CA, USA). Ribosomal RNA was depleted
from DNase-treated samples using Ribominus Eukaryote Kit
(Invitrogen) followed by ethanol precipitation. cDNA synthesis and
library preparation then followed the protocol described in [58].
Isolation of nuclei and nuclear run-on reaction for was carried
out as as described for GRO-Seq [24]. Ten million nuclei was
used in the NRO-reaction. RNA was isolated using TRIZOL
reagent (Invitrogen, Carlsbad, CA, USA) and treated with
TURBO DNase (Ambion, Austin, TX, USA). Base hydrolysis
was performed using RNA fragmentation reagents (Ambion) and
the reaction was purified through p-30 RNAse-free spin column
(BioRad Hercules, CA, USA). Samples were dephosphorylated
with Antarctic phophatase and GRO-Seq samples were immuno-
purified using Anti-deoxyBrU beads (sc-32323AC, Santa Cruz).
cDNA synthesis and library preparation was performed as
described in [58]. Information on antibody, cell type, treatment
and mapped reads is provided in Table S1.
High-throughput sequencing and normalization
DNA from chromatin immunoprecipitation (10–50 ng) was
adapter-ligated and PCR amplified according to the manufactur-
er’s protocol (Illumina). ChIP fragments were sequenced for 36
cycles on an Illumina Genome Analyzer according to the
manufacturer’s instructions. The first 25 bp (32 bp for RNA-
Seq/GRO-Seq) for each sequence tag returned by the Illumina
Pipeline was aligned to the mm8 assembly (NCBI Build 36) using
ELAND allowing up to 2 mismatches. Only tags that mapped
uniquely to the genome were considered for further analysis.
Analyzed ChIP-Seq experiment that were published previously
can be found in the GEO database under accession numbers
GSE21512 and GSE19553 or from [33]. Data analysis was
performed using HOMER, a software suite for ChIP-Seq analysis
and created in part to support this study. Each ChIP-Seq
experiment was normalized to a total of 10
7 uniquely mapped
tags by adjusting the number of tags at each position in the
genome to the correct fractional amount given the total tags
mapped. This normalization was used for all downstream analysis.
ChIP-Seq experiments where visualized by preparing custom
tracks for the UCSC Genome browser in a manner similar to that
previously described [59]. Tag densities at each promoter were
determined by first adjusting the position of each tag by half of the
estimated length of the isolated ChIP fragments. Tags were then
summed for each promoter for gene-specific levels (e.g., Figure 2A)
Mechanisms Establishing TLR4-Responsive Promoters
PLoS Genetics | www.plosgenetics.org 12 December 2011 | Volume 7 | Issue 12 | e1002401or at each position in the promoter to create a profile (e.g.,
Figure 2D). Pol II and GRO-Seq density within gene bodies was
determined by adding the number of tags within the gene body
defined by RefSeq and normalizing by the length of the gene.
Total RNA exon and intron tag densities were calculated by
adding the number of strand-specific tags found within exons and
introns defined by RefSeq and dividing these totals by the lengths
of these features. The implemented methods are freely available at
http://biowhat.ucsd.edu/homer/.
De novo motif discovery using promoter sequences
Motif discovery was performed using HOMER (http://
biowhat.ucsd.edu/homer/, described in Heinz et al. [46]). For
the purposes of this study, macrophage CAGE data (Capped
Analysis of Gene Expression, Carninci et al [60]) was analyzed to
accurately identify the TSS. For each gene, CAGE tags within
1 kb of the annotated TSS (RefSeq) were collected. The 100 bp
region with the highest density of CAGE tags near each gene was
considered the primary TSS cluster, and the single bp within that
cluster with the highest number of CAGE tags was assigned as the
TSS. De novo motif discovery was carried out using the sequences
from 2500 to +100 bp relative to the TSS.
Supporting Information
Figure S1 A. Comparison of normalized signal intensities for I/E
genes in untreated elicited and bone marrow-derived macrophages.
B. Comparison of normalized signal intensities for late genes in
untreated elicited and bone marrow-derived macrophages. C.
Frequency distribution of GC content of I/E and late promoters.
(TIF)
Figure S2 Global and gene-specific profiles of H3K4me3,
H3K9/14ac, and Pol II in resting and activated macrophages.
A. Global distribution of H3K4me3 at the promoters of the
indicated classes of genes aligned at the transcriptional start site
under basal conditions. B. Global distribution of H3Kme3 of the
indicated classes of genes in resting and KLA-stimulated (1 h)
macrophages. C. Distribution of total RNA sequencing reads/kb
for all genes, I/E (Early) and late genes based on ChIP-Seq reads
from elicited macrophages obtained under basal conditions.
(TIF)
Figure S3 Global distribution of H4K5ac, H4K8ac and
H4K12ac at E/I (A) and late (B) gene promoters under control
and after 1 h KLA treatment in elicited peritoneal macrophages.
(TIF)
Figure S4 PU.1 establishes promoter H3K4me3 and basal
expression required for KLA activation of a subset of TLR4-
responsive genes. ChIP-Seq and GRO-Seq experiments were
performed in PU.1-null hematopoietic progenitor cells (PU.1 KO)
and in PUER cells treated with tamoxifen for the indicated times.
Genome browser images are shown for Cxcl2 (A), Il1rn (B) and
Clptm1 (C). Tracks from top to bottom are H3K4me3 tags in PU.1
KO cells, H3K4me3 tags in PUER cells cultured for 24h with
tamoxifen, H3K4me3 tags in PUER cells cultured for 48 h with
tamoxifen, PUER (PU.1 binding activity) tags in PUER cells
cultured for 24 h with tamoxifen, C/EBPb tags in PU.1 KO cells,
C/EBPb tags in PUER cells cultured for 24 h with tamoxifen,
mRNA-strand specific GRO-Seq tags in untreated PU.1 KO cells,
mRNA-strand specific GRO-Seq tags in PU.1 KO cells treated
with KLA for 1 h, mRNA-strand specific GRO-Seq tags in PUER
cells cultured in tamoxifen for 24 h, and mRNA-strand specific
GRO-Seq tags in PUER cells cultured in tamoxifen for 24 h and
treated with KLA for 1 h.
(TIF)
Table S1 Summary table for ChIP-Seq, RNA-Seq, and GRO-
Seq experiments. The antibody column indicates the specific
target and source of antibody for ChIP-Seq experiments, or
designates the experiment as an RNA-Seq or GRO-Seq
experiment. The Cell Type/Treatment column indicates the cell
type and treatment conditions. The Total Mapped Reads column
indicates the total mapped reads used for analysis for each
experiment.
(DOC)
Dataset S1 Cumulative ChIP-Seq, RNA-Seq, GRO-Seq and
microarray data for the I/E genes displayed in Figure 1A.
(XLS)
Dataset S2 Cumulative ChIP-Seq, RNA-Seq, GRO-Seq and
microarray data for the Late genes displayed in Figure 1B.
(XLS)
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